{"id":"https://openalex.org/W7159686384","doi":"https://doi.org/10.3389/fimmu.2026.1731798","title":"Immunotherapy-associated dysgraphia as an early neurocognitive manifestation of immune effector cell\u2013associated neurotoxicity syndrome: clinical characteristics, mechanistic insights, and assessment challenges","display_name":"Immunotherapy-associated dysgraphia as an early neurocognitive manifestation of immune effector cell\u2013associated neurotoxicity syndrome: clinical characteristics, mechanistic insights, and assessment challenges","publication_year":2026,"publication_date":"2026-04-29","ids":{"openalex":"https://openalex.org/W7159686384","doi":"https://doi.org/10.3389/fimmu.2026.1731798","pmid":"https://pubmed.ncbi.nlm.nih.gov/42136681","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13167948"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1731798","doi":"https://doi.org/10.3389/fimmu.2026.1731798","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1731798","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1731798/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1731798/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028441987","display_name":"Yasuto Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128349","display_name":"Kanazawa Medical University Hospital","ror":"https://ror.org/03q129k63","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210128349"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuto Yamamoto","raw_affiliation_strings":["Department of Pharmacy, Kanazawa Medical University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Kanazawa Medical University Hospital","institution_ids":["https://openalex.org/I4210128349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071445880","display_name":"Togen Masauji","orcid":"https://orcid.org/0009-0000-5897-8800","observed_orcids":["https://orcid.org/0009-0000-5897-8800"]},"institutions":[{"id":"https://openalex.org/I4210128349","display_name":"Kanazawa Medical University Hospital","ror":"https://ror.org/03q129k63","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210128349"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Togen Masauji","raw_affiliation_strings":["Department of Pharmacy, Kanazawa Medical University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Kanazawa Medical University Hospital","institution_ids":["https://openalex.org/I4210128349"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072908231","display_name":"Takeo Shimasaki","orcid":"https://orcid.org/0009-0001-5490-8271","observed_orcids":["https://orcid.org/0009-0001-5490-8271"]},"institutions":[{"id":"https://openalex.org/I16568816","display_name":"Kanazawa Medical University","ror":"https://ror.org/0535cbe18","country_code":"JP","type":"education","lineage":["https://openalex.org/I16568816"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takeo Shimasaki","raw_affiliation_strings":["Medical Research Institute, Kanazawa Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Institute, Kanazawa Medical University","institution_ids":["https://openalex.org/I16568816"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072908231"],"corresponding_institution_ids":["https://openalex.org/I16568816"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1731798","last_page":"1731798"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3752000033855438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3752000033855438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.25099998712539673,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":0.1339000016450882,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.9629999995231628},{"id":"https://openalex.org/keywords/dysgraphia","display_name":"dysgraphia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/t-cell-engaging-antibody","display_name":"T cell-engaging antibody","score":0.9760000109672546},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/neurocognitive-impairment","display_name":"neurocognitive impairment","score":0.6899999976158142},{"id":"https://openalex.org/keywords/executive-dysfunction","display_name":"executive dysfunction","score":0.9020000100135803},{"id":"https://openalex.org/keywords/handwriting-assessment","display_name":"handwriting assessment","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C172467417","wikidata":"https://www.wikidata.org/wiki/Q1670397","display_name":"Neurocognitive","level":3,"score":0.6780999898910522},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6000000238418579},{"id":"https://openalex.org/C2775946201","wikidata":"https://www.wikidata.org/wiki/Q584560","display_name":"Dysgraphia","level":4,"score":0.5690000057220459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5166000127792358},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.5012999773025513},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.4745999872684479},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4059999883174896},{"id":"https://openalex.org/C2779386606","wikidata":"https://www.wikidata.org/wiki/Q2393642","display_name":"Handwriting","level":2,"score":0.3675999939441681},{"id":"https://openalex.org/C2779422653","wikidata":"https://www.wikidata.org/wiki/Q2836","display_name":"Aphasia","level":2,"score":0.35120001435279846},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3456999957561493},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33709999918937683},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.30649998784065247},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30399999022483826},{"id":"https://openalex.org/C2778621155","wikidata":"https://www.wikidata.org/wiki/Q576349","display_name":"Encephalopathy","level":2,"score":0.2676999866962433},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.25540000200271606}],"mesh":[{"descriptor_ui":"D000381","descriptor_name":"Agraphia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D000381","descriptor_name":"Agraphia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020258","descriptor_name":"Neurotoxicity Syndromes","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D020258","descriptor_name":"Neurotoxicity Syndromes","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D020258","descriptor_name":"Neurotoxicity Syndromes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1731798","doi":"https://doi.org/10.3389/fimmu.2026.1731798","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1731798","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1731798/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13167948","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13167948/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13167948/pdf/fimmu-17-1731798.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42136681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42136681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:dea272e0372a415595561a77b95219c9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dea272e0372a415595561a77b95219c9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1731798","doi":"https://doi.org/10.3389/fimmu.2026.1731798","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1731798","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1731798/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322311","display_name":"Kanazawa Medical University","ror":"https://ror.org/0535cbe18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7159686384.pdf","grobid_xml":"https://content.openalex.org/works/W7159686384.grobid-xml"},"referenced_works_count":93,"referenced_works":["https://openalex.org/W74687677","https://openalex.org/W1493522514","https://openalex.org/W1558914793","https://openalex.org/W1596326515","https://openalex.org/W1987057544","https://openalex.org/W2001416868","https://openalex.org/W2003340244","https://openalex.org/W2014004239","https://openalex.org/W2030588597","https://openalex.org/W2035981790","https://openalex.org/W2044309123","https://openalex.org/W2049479916","https://openalex.org/W2061580737","https://openalex.org/W2062002104","https://openalex.org/W2073109953","https://openalex.org/W2077216169","https://openalex.org/W2083298058","https://openalex.org/W2098676147","https://openalex.org/W2114458368","https://openalex.org/W2118796952","https://openalex.org/W2129702476","https://openalex.org/W2132485651","https://openalex.org/W2138225709","https://openalex.org/W2148596263","https://openalex.org/W2170781453","https://openalex.org/W2182631734","https://openalex.org/W2261397736","https://openalex.org/W2310709545","https://openalex.org/W2326297993","https://openalex.org/W2326899164","https://openalex.org/W2329132457","https://openalex.org/W2339675637","https://openalex.org/W2341327024","https://openalex.org/W2409935314","https://openalex.org/W2566677727","https://openalex.org/W2591709377","https://openalex.org/W2595999211","https://openalex.org/W2613929012","https://openalex.org/W2735858290","https://openalex.org/W2740630130","https://openalex.org/W2750650202","https://openalex.org/W2754562068","https://openalex.org/W2763751953","https://openalex.org/W2767013919","https://openalex.org/W2773804840","https://openalex.org/W2787301955","https://openalex.org/W2801828108","https://openalex.org/W2805523469","https://openalex.org/W2883690493","https://openalex.org/W2885496269","https://openalex.org/W2888615115","https://openalex.org/W2891697907","https://openalex.org/W2899385155","https://openalex.org/W2903062212","https://openalex.org/W2903225254","https://openalex.org/W2905654445","https://openalex.org/W2944288721","https://openalex.org/W2996215922","https://openalex.org/W2998470023","https://openalex.org/W3007915446","https://openalex.org/W3027149337","https://openalex.org/W3028763463","https://openalex.org/W3082855561","https://openalex.org/W3085294374","https://openalex.org/W3120690860","https://openalex.org/W3120728753","https://openalex.org/W3135480995","https://openalex.org/W3150462000","https://openalex.org/W3165847087","https://openalex.org/W3194193590","https://openalex.org/W3195673681","https://openalex.org/W4213437837","https://openalex.org/W4233024445","https://openalex.org/W4281774528","https://openalex.org/W4288489537","https://openalex.org/W4290758651","https://openalex.org/W4294636962","https://openalex.org/W4297498035","https://openalex.org/W4312115076","https://openalex.org/W4318478271","https://openalex.org/W4319440415","https://openalex.org/W4376121933","https://openalex.org/W4380050024","https://openalex.org/W4380324860","https://openalex.org/W4387455754","https://openalex.org/W4389736219","https://openalex.org/W4390536891","https://openalex.org/W4396666425","https://openalex.org/W4402827909","https://openalex.org/W4404927294","https://openalex.org/W4405679429","https://openalex.org/W4409555335","https://openalex.org/W4413140461"],"related_works":["https://openalex.org/W4390536891","https://openalex.org/W4389369017","https://openalex.org/W4389639558","https://openalex.org/W3199040819","https://openalex.org/W3195673681","https://openalex.org/W4415727890","https://openalex.org/W4310159718","https://openalex.org/W4412688391","https://openalex.org/W4396666425","https://openalex.org/W7116766022"],"abstract_inverted_index":{"Background:":[0],"Immune":[1],"effector":[2,19,97],"cell":[3,98],"therapies,":[4],"including":[5,36],"chimeric":[6],"antigen":[7],"receptor":[8],"T-cell":[9],"(CAR-T)":[10],"therapy":[11],"and":[12,38,69,72,105,132,144,155,226,232,243,252],"T-cell-engaging":[13],"antibodies,":[14],"are":[15],"associated":[16,94],"with":[17,95,108],"immune":[18,96],"cell-associated":[20],"neurotoxicity":[21,255],"syndrome":[22],"(ICANS),":[23],"a":[24,47,190],"clinically":[25,221],"recognized":[26],"immune-mediated":[27],"neurotoxicity.":[28],"Among":[29],"its":[30,67,165],"neurological":[31],"manifestations,":[32],"writing":[33,42,92,194],"impairment":[34,93,148],"(dysgraphia),":[35],"paligraphia":[37],"other":[39],"forms":[40],"of":[41,52,120,129,153,162,193,224,235,241,254],"disturbance,":[43],"has":[44],"emerged":[45],"as":[46,206,229],"potentially":[48],"sensitive":[49,233],"clinical":[50,61,68],"marker":[51],"higher-order":[53,236],"cortical":[54,237],"dysfunction.":[55,146,238],"Objective:":[56],"This":[57],"review":[58],"synthesizes":[59],"current":[60,202],"evidence":[62,126],"on":[63,212],"ICANS-associated":[64,187],"dysgraphia,":[65,137],"characterizes":[66],"neurocognitive":[70],"features,":[71],"examines":[73],"limitations":[74,119],"in":[75,256],"existing":[76],"assessment":[77,203,246],"frameworks.":[78],"Methods:":[79],"A":[80],"structured":[81,242],"literature":[82],"search":[83],"was":[84],"conducted":[85],"using":[86],"PubMed":[87],"to":[88,117],"identify":[89],"reports":[90,111,131,171],"describing":[91,135],"therapies.":[99],"Studies":[100],"were":[101],"selected":[102],"through":[103,113],"title":[104],"abstract":[106],"screening,":[107],"additional":[109],"relevant":[110],"identified":[112],"manual":[114],"reference":[115],"screening":[116],"address":[118],"keyword-based":[121],"indexing.":[122],"Results:":[123],"The":[124,239],"available":[125],"consists":[127],"primarily":[128],"case":[130],"small":[133],"series":[134],"early-onset":[136],"frequently":[138],"characterized":[139],"by":[140,201],"paligraphia,":[141],"spatial":[142],"disorganization,":[143],"executive":[145],"Writing":[147],"typically":[149],"emerges":[150],"within":[151],"days":[152],"infusion":[154],"often":[156],"occurs":[157],"during":[158],"the":[159,207],"early":[160,231,250],"phase":[161],"ICANS.":[163],"Although":[164],"precise":[166],"frequency":[167],"remains":[168],"unknown,":[169],"published":[170],"suggest":[172],"that":[173,186,196],"dysgraphia":[174,188],"may":[175,227,248],"be":[176],"under-recognized":[177,219],"rather":[178],"than":[179],"truly":[180],"rare.":[181],"Importantly,":[182],"these":[183],"findings":[184],"indicate":[185],"represents":[189,217],"heterogeneous":[191],"spectrum":[192],"abnormalities":[195],"is":[197],"not":[198],"adequately":[199],"captured":[200],"tools":[204],"such":[205],"ICE":[208],"score,":[209],"which":[210],"rely":[211],"binary":[213],"evaluation.":[214],"Conclusions:":[215],"Dysgraphia":[216],"an":[218,230],"but":[220],"meaningful":[222],"manifestation":[223],"ICANS":[225],"serve":[228],"indicator":[234],"development":[240],"quantitative":[244],"handwriting":[245],"strategies":[247],"improve":[249],"detection":[251],"monitoring":[253],"patients":[257],"receiving":[258],"immunotherapy.":[259]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-05-02T00:00:00"}